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Abstract 
Introduction: A functional variable number of tandem repeats (VNTR) polymorphism of the promoter region of the monoamine oxidase A (MAOA) gene has 
been described and many studies have investigated the association of this polymorphism with human behaviors, as well as with several psychiatric disorders. 
Objective: This study aimed to review the literature on the role of the VNTR functional polymorphism of the promoter region of the MAOA gene on the mo-
dulation of human behavior for the development of psychiatric disorders. Method: Searches on the Medline, Embase, Web of Science and PsycInfo databases 
were performed including works from January 1998 to June 2009. The words used were: “MAOA and human behavior” and “MAOA and psychiatry”. Results: 
Several studies were found (N = 3,873). After the selection process, 109 papers were included in the review. There was found an association of MAOA low activity 
alleles with antisocial personality disorder, conduct disorder, ADHD, pathological gambling, and substance abuse. High activity alleles were associated with 
neuroticism, anorexia nervosa and depression and anxiety disorders. There was no association between the MAOA polymorphisms and bipolar disorder and 
schizophrenia. Discussion: The main findings, summarized in this paper, support a role of MAOA VNTR polymorphism in some psychiatric disorders although 
some divergences were found due to methodological difficulties in genetic studies. In general, the studies associated the low activity alleles with impulsivity 
and aggressive behavior (“hyperactive behaviors”), and the high activity alleles of the gene with “hypoactive behaviors”, such as depression and anxiety, which 
demonstrates a modulation of the MAOA enzyme in “hyperactive” and “hypoactive” disorders.
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Resumo
Introdução: Muitos estudos têm investigado a associação do polimorfismo VNTR (número variável de repetições em série) localizado na região promotora do 
gene da enzima monoamina oxidase A (MAOA) com alterações no comportamento humano e em diversos transtornos psiquiátricos. Objetivo: O objetivo do 
presente trabalho foi revisar a literatura sobre a participação desse polimorfismo funcional na modulação do comportamento humano para o desenvolvimento 
dos transtornos psiquiátricos. Método: A pesquisa foi realizada na literatura em inglês, de janeiro de 1998 a junho de 2009, disponível no Medline, Embase, 
Web of Science e na base de dados PsycInfo, utilizando os seguintes termos: “MAOA e comportamento humano” e “MAOA e psiquiatria”. Resultados: Foram 
encontrados 3.873 estudos. Desses, 109 foram selecionados e incluídos na revisão. Encontrou-se associação de alelos de baixa atividade do VNTR com transtorno 
de personalidade antissocial, transtorno de conduta, transtorno de déficit de atenção e hiperatividade, jogo patológico e dependência de substâncias. Alelos 
da alta atividade da MAOA foram associados a depressão, ansiedade, neuroticismo e anorexia nervosa. Não se encontrou associação entre polimorfismos da 
MAOA e esquizofrenia e transtorno bipolar. Conclusão: Os principais achados dão suporte ao papel do polimorfismo VNTR da região promotora do gene da 
MAOA em alguns transtornos psiquiátricos, apesar das divergências encontradas devidas às dificuldades metodológicas de estudos em genética. De modo geral, 
os estudos associam os alelos de baixa atividade da MAOA com comportamentos impulsivos e agressivos (“comportamentos hiperativos”), enquanto os alelos 
de alta atividade do gene são mais associados a “comportamentos hipoativos”. 
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Introduction
Monoamine oxidase (MAO) is an outer membrane mitochondrial 
enzyme that catalyses the degradation of several amines, including 
the neurotransmitters serotonin, noradrenaline and dopamine1. Two 
isoenzymes of MAO have been described, named A and B. MAOA 
preferentially acts on serotonin and noradrenaline; MAOB acts on 
phenylethylamines and benzylamine, while dopamine is a substrate 
of both forms of MAO2. 
The MAOA gene (MAOA) is located on the short arm of the X 
chromosome between bands Xp11.23 and Xp11.43, and has 15 exons 
in its structure4. Polymorphisms are variations of the base sequences 
of the gene. Polymorphisms may be a change of one base (called 
single nucleotide polymorphism – SNP) or series of repetitions of 
a variable number of bases (variable number of tandem repeats – 
VNTR). Several different polymorphisms have been identified in the 
promoter region and on the introns and exons of the MAOA, but only 
some of them modify the protein activity or its expression levels5-7.
Sabol et al.1 described a promoter region polymorphism that 
significantly affects the transcriptional potential of the MAOA and 
has been largely studied in recent years. It consists of a variable 
number of tandem repeats (VNTR) of a 30-bp sequence located 
approximately 1.2 kb upstream of the coding region and was termed 
as MAOA-mVNTR. This polymorphism originally was described 
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as four variants of the MAOA alleles, which contain 3, 3.5, 4 or 5 
repeats of the 30-bp sequence. The frequencies of these alleles vary 
considerably among different ethnic populations.
The number of repeats influences the efficiency of gene 
transcription. Sabol et al.1 studied three cell lines and reported 
that alleles with 3.5 or 4 repeats are transcribed 2-10 times more 
efficiently than the others, suggesting that there is an “optimum 
length” of the MAOA promoter region. Deckert et al.8 replicated 
these findings and detected an additional rare fifth allele with only 
2 repeats and low transcriptional activity. They also reported that 
the 5-repeat allele had high transcriptional activity in their German 
and Italian female samples. The 3 and 4 repeat alleles were the most 
frequent ones in the different ethnic groups evaluated throughout 
the studies, corresponding to more than 95% of the variance. Se-
veral human and animal model studies have investigated the role 
of the polymorphism MAOA-mVNTR on the etiology of different 
behavior patterns.
The first evidence that MAOA could play an important role 
on human behavior was the description of a large Dutch family 
which presented a new form of mental retardation with prominent 
behavioral abnormalities linked to the X chromosome5. Several 
males in the family were affected by the disturbance and exhibited 
aggressive behavior, with important impulsivity, pyromania, suicide 
attempts, and sexually aberrant behavior (i.e. exhibitionism, voyeu-
rism, grasping or holding of female relatives, and attempted rape). 
The molecular genetics investigation of the affected individuals6 
demonstrated a point mutation in the eighth exon of the MAOA, 
which, in affected males but not in carrier females, was responsible 
for decreased MAOA activity and for this clinical presentation. The 
main objective of the current study was to review and discuss the 
relevant literature on the association of the functional VNTR poly-
morphism in the MAOA promoter region with human psychiatric 
disorders and personality traits. 
Methods
The literature review was carried out in the English literature from 
January 1998 to October 2008 available on Medline, Embase, Web of 
Science and PsycInfo databases using the following terms: “MAOA 
and human behavior”, “MAOA and psychiatry”, and “MAOA and 
psychiatric disorders”. We also searched for MAOA and each of the 
specific psychiatric disorders in these papers and the references cited 
in each article were also reviewed.
Inclusion and exclusion criteria
1. Inclusion criteria: all English language articles that investigated the 
association of the MAOA-mVNTR polymorphism with psychiatric 
disorders and/or personality traits in humans. 
2. Exclusion criteria: articles in which the term “MAOA” was 
mentioned but was not associated neither to this polymorphism 
nor with any human behavior and/or psychiatric disorder. Animal 
studies and non-English studies were excluded.
Results
Several studies concerning this subject were found for MAO-A and 
psychiatric disorders (N = 3,873).
After examining their titles and/or abstracts, studies that focused 
on the VNTR polymorphism of the promoter region of the MAOA, 
and which genotyped patients with any sort of psychiatric disorder 
were selected. 
After the selection process, 109 papers were included in the study. 
Just for didactic purposes, the studies were arranged according to the 
investigated psychiatric disorder or behavior. Besides MAOA, many 
studies evaluated other genes that will be presented with the res-
pective quotation. These studies are presented and discussed below.
Attention deficit hyperactivity disorder (ADHD)
Although the etiology of ADHD is unknown, dopaminergic, 
serotonergic, and noradrenergic pathways have been implicated 
in its pathophysiology. The MAOA enzyme is involved in the de-
gradation of all three neurotransmitters and, therefore, it has been 
suggested as a strong candidate gene for ADHD. The role of the 
MAOA-mVNTR polymorphism in the ADHD pathophysiology 
remains highly controversial. Manor et al.9 reported a role for the 
high activity MAOA-mVNTR alleles (4 and 5 repeats) in conferring 
risk for ADHD, using three research approaches: 1) a family-based 
transmission disequilibrium test (TDT) design to assess preferen-
tial transmission of specific alleles from heterozygous mothers to 
ADHD children; 2) a case-control design comparing genotype and 
allele frequencies between probands and non-related controls; and 
3) a QTL (quantitative trait loci) design to evaluate the effect of the 
MAOA polymorphism on an attention performance test. These 
findings have not been replicated.
Following an opposite direction, one study reported higher 
frequency of the 3-repeat MAOA allele in ADHD probands when 
compared to the control group, and preferential transmission of this 
allele from heterozygous mothers to male ADHD probands10, but 
these findings have not been replicated as well.
Two other studies found no preferential transmission of the 3-re-
peat allele to ADHD subjects, but higher transmission rates of the 
G-allele of the 941G/T SNP of the MAOA11,12. However, haplotype 
analyses revealed a significant transmission increase to ADHD cases 
of a haplotype consisting of the 3-repeat allele of the promoter VNTR, 
the 6-repeat allele of the CA microsatellite and the G-allele of the 
941G/T SNP11 and also of a haplotype consisting of the 3-repeat allele of 
MAOA-mVNTR and the G-allele of the 941G/T SNP to ADHD cases12. 
Lawson et al.13 using case-control and TDT designs did not find 
association between MAOA-mVNTR polymorphism and ADHD, but 
they reported a higher frequency of the 3-repeat allele in the subgroup 
of ADHD children with comorbid conduct problems.
Autism spectrum disorders (ASD)
Yirmiya et al.14 assessed the role of the MAOA-mVNTR polymor-
phism in a group of 49 families with ASD members, including 15 
families with two affected siblings, and did not find association 
between this polymorphism and severity of autistic behaviors. 
However, the 4-repeat allele genotype was associated with lower 
intelligence quotients (IQ) in male probands in the families with 
two affected siblings. 
Alternatively, Cohen et al.15 reported that boys with the 3-re-
peat allele had a mean 20-points lower IQ and more severe autistic 
behavior than children with the 4-repeat allele. Furthermore, in 
their 1-year follow-up testing, those with the low-activity allele 
showed a worsening in IQ with no change in the severity of their 
autistic behavior. Jones et al.16 found that maternal genotypes at the 
MAOA locus may modify IQ in children with autism through the 
intrauterine environment.
A later study examined the severity of ADHD and anxiety symp-
toms in a sample of 5 to 14 year-old Caucasian boys with ASD (n 
= 43) and reported that ASD children with the 4-repeat allele had 
a more severe parent-rated inattention and impulsivity, and more 
teacher-rated symptoms of generalized anxiety17. 
Anxiety disorders
Deckert et al.8 demonstrated greater frequency of the high activity 
longer alleles (3.5, 4 and 5 repeats) among female panic disorder pa-
tients compared to controls. Nevertheless, in a subsequent study, the 
same research group failed to detect a synergic action of the MAOA 
polymorphism with the 5HTT polymorphism in determining risk 
for panic disorder18.
Following the same direction, Samochowiec et al.19 reported 
that the frequencies of the 3.5, 4 and 5 repeat alleles of the MAOA 
36 Nishioka SA, et al. / Rev Psiq Clín. 2011;38(1):34-42
polymorphism (encoding the high activity form of the enzyme) 
were significantly higher in female patients with anxiety disorders, 
specifically with panic attacks and generalized anxiety disorder. 
There was also a trend for a higher frequency of the high activity 
alleles in females with agoraphobia and specific phobia but not with 
social phobia. 
In contrast, Hamilton et al.20 assessed 620 individuals in 70 mul-
tiplex families, and 81 trios consisting of probands (62 females and 
19 males) and their parents, found no relationship between panic 
disorder and MAOA promoter alleles.
Maron et al.21 analyzed the relationship of MAOA-mVNTR 
genotypes and the probability of panic attack induction with 
cholecystokinin-tetrapeptide (CCK-4) infusion in 32 healthy volun-
teers. The results were significant only in the female population, in 
whom the longer alleles of MAOA, as well as the shorter allele of the 
short/long functional 5’ promoter polymorphism of the serotonin 
transporter gene (5HTTLPR), were associated with lower rates of 
CCK-4 induced panic attacks versus the other genotypes. However, 
the same investigators could not replicate this finding in 110 healthy 
volunteers of both genders22.
Mood disorders
Bipolar disorder
Bipolar disorder etiology has been hypothesized as a complex genetic 
model23 which involves the interaction between multiple small effect 
genes and environmental factors. Studies have consistently demons-
trated no association between MAOA-mVNTR polymorphism and 
bipolar disorder2,24-28. Also, there was no association between this 
polymorphism and antidepressant response in depressed bipolar 
patients29. 
Major depressive disorder (MDD)
One study demonstrated an increased frequency of the 4-repeat allele 
among both genders in major depressive disorder (MDD) patients30, 
and another one showed this association only in females with major 
recurrent depression31. However, this could not be confirmed by 
other groups25,27. 
Gutiérrez et al.26 reported an increase of high activity alleles in 
depressed females with an episodic seasonal pattern and a higher 
frequency of MAOA-mVNTR longer allele homozygosity in those 
with psychotic symptoms. 
There is some evidence that the presence of longer alleles (3.5, 
4 and 5-repeats) was also associated with worse antidepressant 
response and lower remission rates in females with MDD28,30. Other 
studies with smaller samples have failed to report any effect of these 
variants in MDD treatment response29,32,33. 
Du et al.34 found no association between MAOA-mVNTR poly-
morphism and depression in males, but haplotype analysis showed 
that one of the haplotypes (EcoRV2-uVNTR1) was significantly more 
frequent among male patients than in controls. 
Interestingly, Cicchetti et al.35 found that adolescents that had 
suffered three or more types of maltreatment (sexual, physical or 
emotional abuse and neglect) and who had the 3-repeat allele (low 
activity) presented significantly more depressive symptoms than 
adolescents with high activity genotypes. They also found that the low 
activity variant of the 5HTTLPR (SS or SL genotypes) was associated 
with higher scores in depression, anxiety and somatic symptoms only 
among sexually abused adolescents with low MAOA-mVNTR activity 
alleles. Kersting et al.36 evaluated patients with major depression and 
a history of bereavement and they found that the longer allele of the 
MAOA-mVNTR was significantly associated with complicated grief 
in females. 
Additional findings of association studies between MAOA and 
mood disorders are summarized on table 1. 
Table 1. Studies investigating the association between the MAOA promoter 
polymorphism and mood disorders
Phenotype/sample Results (reference)
84 Caucasian bipolar disorder patients 
and 84 controls
No association107
550 mood disorders patients and 663 
controls 
No association108
306 families with bipolar probands 
with suicidal behavior 
No association98
409 Han Chinese with bipolar disorder 
and 305 controls
No association of MAOA promoter 
polymorphisms uVNTR and EcoRV 
with bipolar disorder or any of its 
subtypes109
58 Japanese with bipolar disorder and 
68 controls
No association110
56 patients with bipolar disorder and 
58 controls
Significant association of low activity 
allele among females111
132 Chinese subjects with mood 
disorder and 88 controls
MAOA(CA)n locus, the frequency 
of 116 bp allele was higher in the 
female bipolar disorder cases (0.2581) 
compared with that in the female 
unipolar disorder patients (0.1154) (Z = 
2.15, p < 0.05)112
108 Han Chinese patients with bipolar 
disorder and 103 controls 
The risk haplotype 114S was 
associated with bipolar disorder in 
male patients (P = 0.03)113
331 nuclear families from Western 
and Central Canada with one bipolar 
disorder probands
Haplotype TDT was statistically 
significant (LRS = 12.17; df = 3; P = 
0.0068; permutation global significance 
= 0.00098)114
112 Japanese patients (60 bipolar, 52 
unipolar) and 100 controls 
No association115
Anorexia nervosa
An association study investigated the role of MAOA-mVNTR in 
anorexia nervosa, restrictive subtype (AN-R), but there was only a 
trend for the long alleles (3.5 and 4 repeats) to be transmitted more 
frequently from heterozygous mothers to affected children. However, 
the interaction analysis between these polymorphisms and a promo-
ter polymorphism (NETpPR) of the norepinephrine reuptake protein 
gene (SLC6A2) yielded interesting results. Receiving a MAOA long 
allele more than doubled the risk of developing AN-R, but only in 
individuals who were also NETpPR-L4 homozygous. These results 
suggest important involvement of the noradrenergic system in the 
biological underpinnings of AN-R37. 
Urwin and Nunn38 also investigated the epistatic interaction 
between the MAOA-mVNTR and the functional 5HTTLPR. The 
authors reported that the risk of anorexia seems to be higher in 
homozygous individuals with low transporter activity of 5HTTLPR 
(SS) and who also received a MAOA long allele (3.5 or 4 repeats) 
from a heterozygous mother. Moreover, these individuals had a risk 
eight times higher than that conferred by the MAOA long allele alone, 
implying synergistic epistatic interaction between MAOA-mVNTR 
and 5HTTLPR.
Schizophrenia
Association studies showed no association at all between the MAOA 
promoter polymorphism and schizophrenia27,39-43, or between these 
variant alleles and aggressive behavior in schizophrenia patients44-46. 
De Luca et al.47 also found no association between the MAOA-mVN-
TR polymorphism and suicide attempts in schizophrenia patients, or 
interaction between this polymorphism and three other catechol-O-
-methyl transferase gene (COMT) polymorphisms. Matsumoto et al.48 
found no association between the MAOA-mVNTR polymorphism 
and predisposition to tardive dyskinesia in schizophrenia patients.
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polymorphisms have been the target of investigation on susceptibility 
to addictive behavior69, and some of these studies are described below. 
Alcohol dependence
Samochowiec et al.70 and Schmidt et al.71 conducted the first studies 
on the association of the MAOA-mVNTR promoter polymorphism 
and alcohol addiction and reported that the 3-repeat allele was only 
associated with antisocial behavior in alcohol-dependent males. 
Contini et al.72 replicated this association in a male Brazilian sample, 
and also reported association between this genotype and alcohol 
dependence, earlier onset of alcoholism, and comorbid drug abuse 
among those patients. Another study found that genotype contain-
ing at least one 3-repeat allele was twice more frequent in female 
alcohol-dependents73. 
However, Saito et al.74 and Lu et al.75 found no association be-
tween this polymorphism and alcoholism, with or without antisocial 
behavior, in Finnish and Chinese male subjects, respectively. Another 
study did not find association between this polymorphism and sub-
types of alcoholism76. Other studies have also found no association 
between alcoholism and the MAOA77,78.
One study that demonstrated gene and environment (GxE) 
interaction reported that women who were sexually abused and ho-
mozygous for the 3-repeat allele had higher rates of alcoholism and 
antisocial personality disorder and they presented more antisocial 
personality disorder symptoms than abused women homozygous for 
the 4-repeat allele. Heterozygous women displayed an intermediate 
risk pattern. Nevertheless, they did not find association between 
alcoholism/antisocial behavior and MAOA-mVNTR genotype among 
non-abused women79. 
Nilsson et al.80 found that maltreated or abused male adolescents 
with the 3-repeat variant of the MAOA polymorphism showed sig-
nificantly higher scores of alcohol-related problems. In the opposite 
direction, the same group found that the long (4-repeat) variant of 
the MAOA in females interacted significantly with an unfavorable 
environment (poor family relations or maltreatment/abuse/sexual 
abuse) to increase the risk of high scores of alcohol-related problems, 
possibly demonstrating a sex-difference in this interaction81. 
Another study investigated the combined effects of MAOA geno-
type and testosterone measured in cerebrospinal fluid (CSF) on 95 
Finnish male criminal alcoholics, among whom 43 also had antisocial 
personality disorder (ASPD). Higher levels of testosterone were asso-
ciated with increased aggression scores and higher ASPD frequency 
only among individuals with low-activity MAOA genotype82.
A study was designed by Herman et al.83 to examine the gene-
-gene (GxG) interaction between the functional polymorphism 
in the promoter region of the 5HTTLPR and the MAOA-mVNTR 
polymorphism related to binge drinking behavior in college females. 
Interestingly, the highest risk was found in homozygous for the short 
variant allele of the 5HTTLPR (SS) in combination with the higher 
activity forms of the MAOA-mVNTR (HH) (OR = 3.11, 95% CI = 
1.14-18.10), and the lowest risk was found in individuals carrying 
at least one long variant of the 5HTTLPR (LL or LS) in combination 
with higher activity MAOA-mVNTR alleles (HH) (OR = 0.46, 95% 
CI = 0.28-0.71)83.
Another study investigated the association and interaction betwe-
en the TaqI A polymorphism of the dopamine receptor type 2 gene 
(DRD2) and the promoter polymorphism of MAOA and alcoholism, 
with or without comorbid depression/anxiety. The 3-repeat allele was 
associated only with alcoholism without depression/anxiety comor-
bidity and DRD2 A1/A1 and A1/A2 genotypes were associated with 
greater risk of alcoholism with depression/anxiety comorbidity, but 
only in subjects with the 3-repeat allele84. 
Wang et al.85 investigated this same gene interaction in antiso-
cial personality disorder individuals, with or without alcoholism 
and found no association between MAOA-mVNTR polymorphism 
or TaqI A and this personality disorder. However, among subjects 
with the 4-repeat allele, the frequency of the DRD2 A1/A2 genotype 
Neuroticism and personality traits/disorders
Eley et al.49 reported an association between the high function ge-
notypes and high neuroticism scores in males. The 4-repeat allele 
has also been associated with higher scores on “harm avoidance”50, 
“novelty seeking” and “reward dependence”51 and the 3-repeat allele 
has been associated with higher “reward dependence”19.
On the other hand, other studies found no association between 
this polymorphism and personality dimensions or traits in both 
genders52-54. Jacob et al.55 also found no association between the 
MAOA-mVNTR and neuroticism or personality dimensions, except 
that the hemi- and homozygous genotypes for the 3-repeat variant 
was more frequent among cluster B personality disorder patients. 
Another study did not find association between this polymorphism 
alone and neuroticism, but reported a marginally significant gene-
-gene interaction between the MAOA-mVNTR, COMT (Val158Met), 
dopamine receptor type 3 gene (DRD3) (Ser9Gly) polymorphisms 
and agreeableness in Japanese females56. Additionally, no association 
was found between shyness in grade school students and the MAOA 
promoter region polymorphism57. 
Conduct disorder and aggressive/impulsive behavior
Manuck et al.58,59 reported that male subjects with high activity 
MAOA-mVNTR genotypes scored significantly higher on scales 
of aggression than those with low activity genotypes. However, a 
population-based twin study found that homozygosity for the short 
MAOA-mVNTR allele was associated with disruptive behavior in 
boys60.
The classic study by Caspi et al.7 demonstrated that maltreated 
children with low activity MAOA alleles of the VNTR polymorphism 
had a significantly higher risk of developing conduct disorder or 
being involved in crimes when adults, than those with high activity 
alleles. It is important to notice that the effect of the maltreatment 
was weaker among children with high activity alleles. 
Huang et al.61 found higher rates of reported abuse in childhood 
and higher impulsiveness in low activity allele male carriers. These 
authors suggested that this polymorphism could be a marker for 
impulsiveness that, in turn, might contribute for the risk of abuse.
Other studies have showed mixed results about the interaction 
between the low activity MAOA-mVNTR genotype and maltreatment 
in childhood, increasing the risk of conduct and antisocial personality 
disorders in adulthood62-66. 
A meta-analysis67 confirmed that the MAOA-mVNTR promoter 
region polymorphism moderates the development of psychopatho-
logy after exposure to physical abuse, and ruled-out the possibility 
of a spurious finding by accounting for passive and evocative gene-
-environment correlation.
Passamonti et al.68 assessed impulsivity by testing the brain acti-
vity on a Go/NoGo task (a response inhibition task) using functional 
magnetic resonance imaging (fMRI) in 24 healthy men and verified 
its association with the MAOA polymorphism. They reported greater 
response in the right ventrolateral prefrontal cortex (Brodmann’s area 
[BA] 45/47) in high-activity allele carriers, whereas a greater response 
in the right superior parietal cortex (BA 7) and bilateral extrastriate 
cortex (BA 18) was found in low-activity allele carriers, versus the 
other genotypes. These results suggest that this polymorphism can 
modulate selective activations within the neural network assessed 
by the Go/NoGo response-inhibition task. 
Addictive behavior
Under the scope of addiction disorders we included substance-related 
disorders and pathological gambling, which is considered a beha-
vioral dependence90. Considering that MAOA is an enzyme with an 
important role in the metabolism of dopamine, and that release of 
dopamine in the nucleus accumbens is known to be associated with 
reward, reinforcement, and addiction to many substances, MAOA 
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was significantly lower in antisocial alcoholics than in antisocial 
non-alcoholics, suggesting that the DRD2 A1/A2 genotype might 
have a protective effect against alcoholism in antisocial personality 
disorder subjects. 
Tobacco smoking
Ito et al.86 and Jin et al.87 reported that individuals with the 3-repeat 
allele had a greater risk of smoking, when compared to those with 
the 4-repeat allele in Asian populations. In contrast, Wiesbeck et 
al.88 reported an association between the 4-repeat allele and a greater 
quantity of daily cigarettes in Caucasian men with both alcohol and 
tobacco dependence. 
Heroin
One study reported association between the 3-repeat allele of MAOA-
-mVNTR polymorphism and aggressive-antisocial behavior and in-
clination to crime and violence among heroin-addicted individuals89.
Pathological gambling
Pathological gambling is an impulse control disorder and it has also 
been proposed as a model of addiction90. Perez de Castro et al.91 
found that the 3-copy allele was significantly more frequent in male 
gamblers than in controls. This association was stronger for the most 
severe male subpopulation. Moreover, they also reported a significant 
association between the least transcriptional efficient allele of the 
5HTTLPR polymorphism and male gamblers and haplotypes with 
less efficient genotypes. 
Suicidal behavior
Serotonin dysfunction has been strongly implicated in the pathophy-
siology of suicidal behavior and may be a key element in the genetic 
vulnerability to this behavior92. For this reason, the MAOA has been 
a target of research in genetic studies on suicide93.
Sherif et al.94 found a significant elevation in MAOA activity in 
the hypothalamic region of postmortem brains of suicide victims, 
particularly in a subgroup with a history of depression. Nevertheless, 
Mann and Stanley95 did not find differences in MAOA activity in the 
postmortem prefrontal cortex of suicide victims when compared 
with controls.
Two studies failed to find any association between MAOA-
-mVNTR polymorphism and suicidal behavior25,96. Courtet et al.97 
also found no association between MAOA-mVNTR polymorphism 
and suicide in a larger sample of 738 patients (226 men, 512 women). 
However, the authors reported that among males who attempted 
suicide, those carrying low activity allele were at higher risk [OR = 
2.17; 95% CI (1.08-4.35)] of attempting suicide using violent means, 
than those carrying high activity alleles. 
Another study also failed to demonstrate neither a relationship 
between two polymorphisms of the serotonin receptor type 2C gene 
(5HT2C) (Cys23Ser and STR in the promoter region) and suicidality 
in bipolar patients nor a gene-gene interaction of these variations and 
the u-VNTR with 941T/G polymorphisms of the MAOA98.
Tourette syndrome
A number of molecular genetic studies have investigated the as-
sociation between some candidate genes and Tourette syndrome 
(TS), particularly those implicated in dopamine modulation. The 
results of these studies were inconclusive; which may be due to the 
variable ethnicity of the patients included in different studies and/
or the heterogeneity of TS patients. 
Díaz-Anzaldúa et al.99 used the TDT approach, which has proven 
to be a robust family-based association analysis to investigate the 
implication of dopamine-related candidate genes (DRD2, DRD3, 
dopamine receptor type 4 gene – DRD4 –, dopamine transporter 
gene – SLC6A3 and MAOA) in 110 TS patients and their parents 
from French Canadian origin. The study reported that from the 
total MAOA-mVNTR “high-activity” alleles found in heterozygous 
parents, 68% were transmitted to the TS patient. In contrast, from the 
“low-activity” alleles, only 33% were transmitted to affected children. 
Overtransmission of the high activity allele was observed (p = 0.0076)
Table 2 displays a synthesis of results of the association studies 
reported. 
Discussion
The studies presented in this review provide compelling evidence 
that there may be an association of the VNTR polymorphism of the 
MAOA with some human behaviors and at least some psychiatry 
disorders. However, the role of the polymorphism in specific phe-
notypes remains unclear, as both high and low activity alleles have 
been associated to several types of psychopathologic alterations and 
some studies presented in this paper found controversial results. 
This review evidenced an association between MAOA polymor-
phisms and impulsive/aggressive behavior. Most studies with this 
phenotype have found an association with the low activity allele 
(Table 2). Also, four studies have found an association between 
development of impulsive behavior or conduct disorder in children 
exposed to an adverse environment7,61,62,79. The association between 
the low activity allele and some diagnoses such as pathological gam-
bling, alcohol and drug abuse or cluster B personality disorders could 
be mediated by a vulnerability to impulsive behavior. 
Moreover, MAOA was not associated with autism spectrum di-
sorders, but with its severity. Aggressive and impulsive behavior may 
worsen ASD’s patient’s function and reflect in higher severity rates 
on rating scales. Thus, it is also possible that ASD severity could be 
mediated by the aggressive/impulsive behavior and MAOA. 
Despite several studies have found association between the 
COMT gene100,101 and psychotic disorders, there was also a consistent 
lack of association of MAOA-mVNTR and psychotic disorders such 
as schizophrenia and bipolar disorder in this study. Moreover, there 
was no association between personality traits, such as neuroticism, 
harm avoidance, novelty seeking, and reward dependence. For the 
others disorders, the results were controversial, with some studies 
reporting association with low activity alleles and others with high 
activity alleles (ADHD, tobacco and alcohol dependence).
Despite some authors have characterized the suicidal behavior 
as a complex phenotype that involves impulsivity and aggressive-
ness102,103, one of the most consistent findings was the lack of associa-
tion between MAOA polymorphisms and suicidal behavior. Suicide 
is a heterogeneous phenotype92 which involves confounding factors, 
such as gender, and may occur in different disorders. The methods 
utilized in suicide are different between genders and may reflect di-
fferent degrees of impulsivity, and different subtypes and intensities 
of depression. A study that evaluated the association between suicide 
by violent methods and MAOA-mVNTR found that an association 
of more violent means and low activity allele97. 
As data on molecular genetics studies in psychiatry accumulate, 
it has become clearer that a single polymorphism will not explain 
all the phenotypic variance of human behavior. Studies with MDD, 
for example, have found controversial results. Possible explanations 
for this lack of replication in the findings might be the small num-
ber of subjects included in the studies and the ethnical differences 
among samples51,104-106. It is always possible that the polymorphism 
investigated be in linkage disequilibrium with non-identified genes 
or even with other polymorphisms in MAOA, which would be the 
real contributors to the behavior studied. This would justify a bro-
ader investigation of different polymorphisms within MAOA, and 
haplotype studies.
Furthermore, other approaches that must be further explored 
are the gene-gene and gene-environment interaction studies which 
have already presented promising and interesting findings, such as 
the cited above.
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Table 2. Counting of studies results involving MAOA-µVNTR polymorphism in psychiatry
Phenotype Number of studies with 
positive association with 
MAOA low activity alleles
Number of studies with 
positive association with 
MAOA high activity allele
Number of studies with no 
association MAOA-µVNTR 
polymorphism
ADHD 110 19 312,13,105
Higher severity of ASD 115,16 114 0
Panic disorder 0 319,21,28 318, 20,22
GAD 0 119 0
Social phobia 0 0 157
Bipolar disorder 1111 0 122,24-28,61,107,110,113-115
MDD 126 230, 31 3 34, 61, 115
Antidepressant treatment response 328,30,50 0 4 28, 29, 32-34
Suicidal behavior 0 0 725,47,61,93,96-98
Schizophrenia 0 0 627,39-43
Antisocial personality disorder/aggressive behavior/conduct disorder 813, 60,70-72,82,85,89 258,59 274,75
Tardive diskynesia 0 0 148
Neuroticism 0 149 255,56
Harm avoidance 0 150 452-55
Novelty seeking 0 151 452-55
Reward dependency 119 151 452-55
Cluster B personality disorders 155 0 0
Impulsiveness 261 168 0
Alcoholism 372,73,84 0 574-78
Drug abuse 172 0 0
Tobacco use 286,87 188 0
Pathological gambling 191 0 0
Tourette’s syndrome 0 199 0




2 studies: complicated 
grief36; alcoholism81
3 studies: conduct 
disorder63,65,66
MAOA: monoamine-oxidase-A gene; µVNTR: variable number of tandem repeats polymorphism placed on X chromosome between p11.23 e p11.4 regions; ADHD: attention deficit hyperactivity disorder; 
ASD: autism spectrum disorder; GAD: generalized anxiety disorder; MDD: major depressive disorder.
Special attention must be given to the differential role of the 
MAOA-mVNTR according to gender, as for MAOA is located in the 
X sexual chromosome3. This aspect has been investigated, yielding 
differential associations with some psychiatric disorders, such as 
depression and some anxiety disorders, according to the patients’ 
gender. 
In general, studies have found association between “hyperactive 
behaviors”, such as impulsivity, aggressiveness and some psychiatric 
disorders in which these components are more frequent, such as an-
tisocial personality disorder, conduct disorder, ADHD, pathological 
gambling, and substance dependence with low activity alleles. A 
simplistic explanation would be that these behaviors would be related 
to brain monoaminergic hyperactivity. On the contrary, “hypoactive 
behaviors”, such as depression, anxiety, neuroticism, and anorexia 
nervosa have been associated with a monoaminergic hypoactivity in 
the brain and associated to high enzymatic activity alleles of MAOA.
The controversial results among the studies are related to the 
heterogeneity of psychiatric disorders and to the fact that point 
mutations are rarely related to psychiatric disorders as we classify 
them according to DSM. A more successful approach would be to 
search for associations with more restricted phenomena, such as 
personality traits, symptoms or small groups of symptoms, and, 
preferentially, endophenotypes.
Due to the discrepancies between findings in different studies 
which investigated association of a single phenotype and a specific 
polymorphism, studies have started to investigate the relation of 
groups of phenotypes, and also their relation with the environment. 
Studies on depression and alcoholism demonstrate clearly the 
importance of gene x environment interaction (abuse in studies 
on depression; and antisocial personality disorder in studies on 
alcoholism, for example). 
In conclusion, the search for genetic susceptibility of mental 
disorders is warranted specially under new paradigms such as their 
interaction with the environment and other endophenotypic varia-
bles which have been investigated through neuropsychological and 
neuroimaging evaluations.  
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